Ruti Aga's six-year ban: the fake prescription outweighed the positive test

Ruti Aga's six-year ban: the fake prescription outweighed the positive test

The clinic named on the prescription does not exist. The person who signed as "doctor" holds no medical registration number. The prescription pad was said to come from a former workplace, and that workplace confirmed she never worked there for a single day. Three independent verification layers, three collapses. Ruti Aga — the 32-year-old Ethiopian winner of the 2026 Tokyo Marathon — has received a six-year ban announced by the Athletics Integrity Unit (AIU). Of those six years, two belong to the prohibited substance found in her sample and four belong to the falsification of documents. The heavier penalty sits outside the doping story itself.

That is the point I want to hold onto before going into any other detail.

Context: a world-class athlete, a minor race in China

Aga's competitive record is not up for debate. She won the 2026 Tokyo Marathon — one of the six World Marathon Majors, the most prestigious group of road races on the planet. She has three runner-up finishes at World Marathon Majors events. Over 42.195 kilometres, that is the genuine elite tier of women's distance running, not a category inflated by media attention.

The positive test followed a half marathon in China in March, which she won. The substance detected was methylprednisolone.

Here I have to pause, because most reports call it a "steroid" — and that framing distorts the entire reference frame. Methylprednisolone is a synthetic glucocorticoid, meaning a corticosteroid, not an anabolic steroid. In the WADA list it sits in class S9, prohibited in-competition only, and is classified as a "Specified Substance" — a group the authorities acknowledge is more plausibly linked to therapeutic or inadvertent use. The baseline sanction for that group, absent proof of intent to enhance performance, is two years.

Aga stated she was treating a knee injury. A corticosteroid course for a knee joint is an entirely plausible medical scenario for a 32-year-old marathoner. The problem lies elsewhere: there was no TUE — no valid Therapeutic Use Exemption — and no medical record behind it.

The case was handled by the Athletics Integrity Unit, World Athletics' independent integrity body, not by a race organiser. It oversees everything from sample collection and results management to prosecution, applying the WADA Code. A small half marathon in China therefore produced a globally enforceable sanction.

The core: the arithmetic of six years and the price of one sheet of paper

The structure of the sanction reads clearly: two years for the presence of a prohibited substance, plus four years for tampering with the results-management process, served consecutively rather than concurrently. The WADA Code requires separate violations to be served back to back. Had Aga simply tested positive and honestly declared a treatment course, the likely outcome sat around two years, possibly less with a retroactive TUE and a demonstrated legitimate route of administration.

Instead, her side produced a forged prescription. And the forgery carried the hallmarks of someone with no compliance expertise: a fictitious clinic, a signatory who was a family member without medical registration, an explanation involving an old prescription pad. The AIU only had to make a phone call for the chain to fall apart.

The principle I set for myself in 2026: I never issue a judgement before looking at the numbers. Even when instinct says otherwise. In this file the numbers are unambiguous — four is bigger than two. The cover-up was judged twice as severely as the original act. Within the anti-doping system that is deliberate design: protecting the integrity of the investigative process matters more than protecting an individual. But it also reflects another reality, that the system punishes panic more heavily than it punishes medical error.

What is notable is how cleanly the AIU did its work. Direct verification with the clinic, a check on the registration number, cross-referencing with the former employer. Three steps, none requiring advanced technology. The forgery finding rests on hard evidence, not inference. A forged file of this kind today has almost no chance of surviving more than a few weeks.

There is a further layer rarely mentioned. Aga was competing at 32 — still inside the peak window of women's marathon running, where many athletes hold form past 35. A six-year ban running from 10 September returns her at roughly 38. Theoretically, a 38-year-old female marathoner can still compete. Realistically, after six years without racing, without invitations, without appearing at major events, the probability of returning to World Marathon Majors podium level is close to zero. This sanction ends a career; it is not a temporary suspension.

And another layer: the March half marathon in China. That result will almost certainly be annulled, along with its prize money. For an East African distance runner, income does not come from club salaries but from appearance fees at international road races — a distinct economy in which Chinese events pay for marquee names. Cutting that source for six years cuts the entire revenue stream. It is a double penalty: losing the result and losing commercial standing at once.

The contrarian angle: the media is telling the wrong story

The common framing is "another doping athlete". That framing skips two things.

First, the substance half of this case is the softer half. Methylprednisolone is classified as Specified precisely because it is bound up with therapeutic scenarios. A 32-year-old treating a knee with a corticosteroid is ordinary sports medicine. With correct declaration and a TUE, there may well have been no case at all.

Second, what makes this story memorable lies elsewhere: a career destroyed by a sheet of paper signed by a relative. And that is the detail the public will remember longest, because it looks more like a tragedy than a conspiracy.

Generalisation also needs limits. Ethiopia has enormous depth in women's marathon running; one banned athlete does not shift the balance of the event. But it is not evidence of a national doping system. This is an individual case, clumsily handled, lacking professional medical and legal support structures. Data does not discriminate by gender. Only bias does that — and only bias turns a clumsy forged file into a claim about an entire nation.

Across 34 years of observing this industry, I keep seeing one pattern: distance runners from developing countries often have no dedicated compliance lawyer, no TUE adviser, no one to read a rulebook hundreds of pages thick on their behalf. When trouble arrives, they improvise. And improvising inside the anti-doping system is the fastest route to turning two years into six.

A comment ignored years ago becomes a lecture for the next generation. The line I still give young colleagues in Da Nang after every broadcast: if you remember only one thing about doping rules, remember that the most frightening part of the code is not the prohibited list — it is the chapter on tampering.

Takeaway

Six years. A peak career usually lasts about ten. Aga has just handed over more than half of hers for a prescription whose clinic never existed.

The question I leave with those working in youth development: when a 20-year-old signs to race abroad, who sits down with her and explains that declaring a knee injection properly takes ten minutes, while forging it takes six years?